Skip Content
You are currently on the new version of our website. Access the old version .

779 Results Found

  • Review
  • Open Access
97 Citations
10,267 Views
19 Pages

29 December 2021

Angiogenesis is a process associated with the migration and proliferation of endothelial cells (EC) to form new blood vessels. It is involved in various physiological and pathophysiological conditions and is controlled by a wide range of proangiogeni...

  • Review
  • Open Access
24 Citations
9,007 Views
32 Pages

Yersinia pestis Plasminogen Activator

  • Florent Sebbane,
  • Vladimir N. Uversky and
  • Andrey P. Anisimov

14 November 2020

The Gram-negative bacterium Yersinia pestis causes plague, a fatal flea-borne anthropozoonosis, which can progress to aerosol-transmitted pneumonia. Y. pestis overcomes the innate immunity of its host thanks to many pathogenicity factors, including p...

  • Review
  • Open Access
12 Citations
4,979 Views
21 Pages

24 February 2023

Stressful events trigger a set of complex biological responses which follow a bell-shaped pattern. Low-stress conditions have been shown to elicit beneficial effects, notably on synaptic plasticity together with an increase in cognitive processes. In...

  • Article
  • Open Access
10 Citations
4,035 Views
12 Pages

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women

  • Hee Young Cho,
  • Han Sung Park,
  • Eun Hee Ahn,
  • Eun Ju Ko,
  • Hyeon Woo Park,
  • Young Ran Kim,
  • Ji Hyang Kim,
  • Woo Sik Lee and
  • Nam Keun Kim

16 December 2021

Recurrent pregnancy loss (RPL) is defined as two or more consecutive pregnancy losses prior to 20 weeks of gestational age. Various factors, including immune dysfunction, endocrine disorders, coagulation abnormality, and genetic disorders influence R...

  • Article
  • Open Access
1,579 Views
14 Pages

Recombinant Plasminogen Activator of the Sandworm (Perinereis aibuhitensis) Expression in Escherichia coli

  • Tuo Song,
  • Xiaozhen Diao,
  • Jun Cheng,
  • Yang Man,
  • Boyu Chen,
  • Haixing Zhang and
  • Wenhui Wu

As an essential thrombolytic agent, the tissue plasminogen activator receives increasing attention due to its longer half-life, lower immunogenicity, and easier administration, which are superior to other thrombolytic agents. In this study, the isola...

  • Review
  • Open Access
99 Citations
12,711 Views
17 Pages

Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases

  • Yao Ye,
  • Aurelia Vattai,
  • Xi Zhang,
  • Junyan Zhu,
  • Christian J. Thaler,
  • Sven Mahner,
  • Udo Jeschke and
  • Viktoria Von Schönfeldt

Normal pregnancy is a state of hypercoagulability with diminishing fibrinolytic activity, which is mainly caused by an increase of plasminogen activator inhibitor type 1 (PAI-1). PAI-1 is the main inhibitor of plasminogen activators, including tissue...

  • Review
  • Open Access
12 Citations
6,040 Views
11 Pages

18 November 2015

Tissue plasminogen activator (tPA) mediates a number of processes that are pivotal for synaptogenesis and remodeling of synapses, including proteolysis of the brain extracellular matrix, degradation of adhesion molecules, activation of neurotrophins,...

  • Review
  • Open Access
15 Citations
5,285 Views
14 Pages

1 February 2021

Pleural and parenchymal lung injury have long been characterized by acute inflammation and pathologic tissue reorganization, when severe. Although transitional matrix deposition is a normal part of the injury response, unresolved fibrin deposition ca...

  • Review
  • Open Access
142 Citations
14,578 Views
16 Pages

Plasminogen activator inhibitor-1 (PAI-1) is the main physiological inhibitor of plasminogen activators (PAs) and is therefore an important inhibitor of the plasminogen/plasmin system. Being the fast-acting inhibitor of tissue-type PA (tPA), PAI-1 pr...

  • Article
  • Open Access
10 Citations
5,158 Views
8 Pages

Tissue Plasminogen Activator and MRI Signs of Cerebral Small Vessel Disease

  • Larisa A. Dobrynina,
  • Alla A. Shabalina,
  • Maryam R. Zabitova,
  • Elena I. Kremneva,
  • Zukhra Sh. Gadzhieva,
  • Marina V. Krotenkova,
  • Elena V. Gnedovskaya,
  • Alexander B. Berdalin and
  • Lyudmila A. Kalashnikova

5 October 2019

Cerebral small vessel disease (SVD) is one of the leading causes of cognitive impairment and stroke. The importance of endothelial dysfunction and high blood–brain barrier (BBB) permeability in pathogenesis, together with ischemia, is under dis...

  • Article
  • Open Access
8 Citations
6,427 Views
14 Pages

Inhibitors of Urokinase Type Plasminogen Activator and Cytostatic Activity from Crude Plants Extracts

  • Xueqiang Zha,
  • Ricardo Diaz,
  • Jose Javier Rosado Franco,
  • Veronica Forbes Sanchez,
  • Ezio Fasoli,
  • Gabriel Barletta,
  • Augusto Carvajal and
  • Vibha Bansal

26 July 2013

In view of the clear evidence that urokinase type plasminogen activator (uPA) plays an important role in the processes of tumor cell metastasis, aortic aneurysm, and multiple sclerosis, it has become a target of choice for pharmacological interventio...

  • Article
  • Open Access
6 Citations
6,740 Views
7 Pages

2 January 2013

Recombinant tissue plasminogen activator (rt-PA) is used to restore patency and avoid inadvertent removal of peripheral and central venous catheters. rt-PA was reconstituted (1 mg/mL) then cryopreserved at −30 °C for 1, 2, 3, 6, 8, and 12 months and,...

  • Article
  • Open Access
19 Citations
3,232 Views
16 Pages

The urokinase plasminogen activator and its receptor (uPA/uPAR) are biomarkers for metastasis, especially in triple-negative breast cancer. We prepared anti-mitotic N-alkylisatin (N-AI)-loaded liposomes functionalized with the uPA/uPAR targeting liga...

  • Article
  • Open Access
6 Citations
3,407 Views
13 Pages

Role of Macrophages and Plasminogen Activator Inhibitor-1 in Delayed Bone Repair Induced by Glucocorticoids in Mice

  • Kiyotaka Okada,
  • Naoyuki Kawao,
  • Daisho Nakai,
  • Rei Wakabayashi,
  • Yoshitaka Horiuchi,
  • Katsumi Okumoto,
  • Shinji Kurashimo,
  • Yoshimasa Takafuji,
  • Osamu Matsuo and
  • Hiroshi Kaji

Glucocorticoids delay fracture healing and induce osteoporosis. However, the mechanisms by which glucocorticoids delay bone repair have yet to be clarified. Plasminogen activator inhibitor-1 (PAI-1) is the principal inhibitor of plasminogen activator...

  • Article
  • Open Access
1,968 Views
12 Pages

Effects of Ghrelin on Plasminogen Activator Activity in Human Umbilical Vein Endothelial Cells

  • Elisabetta Fiacco,
  • Giovanna Notaristefano,
  • Anna Tropea,
  • Rosanna Apa and
  • Rita Canipari

8 January 2024

Ghrelin and its growth hormone secretagogue receptor (GHSR) have been found in the placenta, both in endothelial and trophoblast cells. Ghrelin has been shown to decrease blood pressure in several systems and improve endothelial function by stimulati...

  • Review
  • Open Access
11 Citations
2,755 Views
15 Pages

The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator

  • Valentina A. Babenko,
  • Ksenia S. Fedulova,
  • Denis N. Silachev,
  • Parvaneh Rahimi-Moghaddam,
  • Yulia N. Kalyuzhnaya,
  • Svetlana V. Demyanenko and
  • Egor Y. Plotnikov

23 July 2023

Ischemic stroke is a leading cause of disability and mortality worldwide. The only approved treatment for ischemic stroke is thrombolytic therapy with tissue plasminogen activator (tPA), though this approach often leads to a severe complication: hemo...

  • Article
  • Open Access
1 Citations
1,362 Views
9 Pages

Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients

  • Simona Arientová,
  • Kateřina Matúšková,
  • Oldřich Bartoš,
  • Ondřej Beran and
  • Michal Holub

23 October 2024

Background/Objectives: This retrospective study analyzed soluble urokinase plasminogen activator receptor (suPAR) plasma levels alongside routine inflammatory markers, including the neutrophil-to-lymphocyte count ratio, C-reactive protein (CRP), inte...

  • Article
  • Open Access
7 Citations
3,181 Views
16 Pages

Arsenite Inhibits Tissue-Type Plasminogen Activator Synthesis through NRF2 Activation in Cultured Human Vascular Endothelial EA.hy926 Cells

  • Tsuyoshi Nakano,
  • Tsutomu Takahashi,
  • Chika Yamamoto,
  • Eiko Yoshida,
  • Toshiyuki Kaji and
  • Yasuyuki Fujiwara

Chronic arsenic exposure is known to be related to the progression of atherosclerosis. However, the pathogenic mechanisms of arsenic-induced atherosclerosis have not been fully elucidated. Because disruption of the blood coagulation/fibrinolytic syst...

  • Article
  • Open Access
6 Citations
3,469 Views
11 Pages

Increased Circulating Levels of Tissue-Type Plasminogen Activator Are Associated with the Risk of Spontaneous Abortion During the First Trimester of Pregnancy

  • Lara J. Monteiro,
  • Manuel Varas-Godoy,
  • Stephanie Acuña-Gallardo,
  • Paula Correa,
  • Gianluca Passalacqua,
  • Max Monckeberg,
  • Gregory E. Rice and
  • Sebastián E. Illanes

Spontaneous abortion is a common complication in early pregnancy, with an incidence of around 20%. Ultrasound scan and measurement of human chorionic gonadotropin are used to identify patients at risk of spontaneous abortion; however, there is a clin...

  • Article
  • Open Access
9 Citations
3,128 Views
15 Pages

A Novel Role for Plasminogen Activator Inhibitor Type-2 as a Hypochlorite-Resistant Serine Protease Inhibitor and Holdase Chaperone

  • Jordan H. Cater,
  • Noralyn B. Mañucat-Tan,
  • Demi K. Georgiou,
  • Guomao Zhao,
  • Irina A. Buhimschi,
  • Amy R. Wyatt and
  • Marie Ranson

29 March 2022

Plasminogen activator inhibitor type-2 (PAI-2), a member of the serpin family, is dramatically upregulated during pregnancy and in response to inflammation. Although PAI-2 exists in glycosylated and non-glycosylated forms in vivo, the majority of in...

  • Article
  • Open Access
8 Citations
3,574 Views
11 Pages

Urokinase-Type Plasminogen Activator Enhances the Neuroprotective Activity of Brain-Derived Neurotrophic Factor in a Model of Intracerebral Hemorrhage

  • Stalik Dzhauari,
  • Svetlana Litvinova,
  • Anastasia Efimenko,
  • Natalia Aleksandrushkina,
  • Nataliya Basalova,
  • Maxim Abakumov,
  • Natalia Danilova,
  • Pavel Malkov,
  • Vadim Balabanyan and
  • Maxim Karagyaur
  • + 9 authors

Brain-derived neurotrophic factor (BDNF) is a classic neuroprotective and pro-regenerative factor in peripheral and central nervous tissue. Its ability to stimulate the restoration of damaged nerve and brain tissue after ischemic stroke and intravent...

  • Article
  • Open Access
8 Citations
2,955 Views
14 Pages

A Novel Marine Pyran-Isoindolone Compound Enhances Fibrin Lysis Mediated by Single-Chain Urokinase-Type Plasminogen Activator

  • Chunli Gao,
  • Simin Tang,
  • Haixing Zhang,
  • Huishu Zhang,
  • Tian Zhang,
  • Bin Bao,
  • Yuping Zhu and
  • Wenhui Wu

30 July 2022

Fungi fibrinolytic compound 1 (FGFC1) is a rare pyran-isoindolone derivative with fibrinolytic activity. The aim of this study was to further determine the effect of FGFC1 on fibrin clots lysis in vitro. We constructed a fibrinolytic system containin...

  • Hypothesis
  • Open Access
2,508 Views
12 Pages

Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review

  • Paola Manzo,
  • Valentina Giudice,
  • Filomena Napolitano,
  • Danilo De Novellis,
  • Bianca Serio,
  • Paolo Moscato,
  • Nunzia Montuori and
  • Carmine Selleri

The microenvironment plays an essential role in multiple myeloma (MM) development, progression, cell proliferation, survival, immunological escape, and drug resistance. Mesenchymal stromal cells and macrophages release tolerogenic cytokines and favor...

  • Feature Paper
  • Article
  • Open Access
2 Citations
3,266 Views
16 Pages

28 July 2022

Leydig cells produce androgens which are essential for male sex differentiation and reproductive functions. Steroidogenesis, as well as expression of several genes in Leydig cells, are stimulated by LH/cAMP and repressed by AMP/AMPK. One of those gen...

  • Benchmark
  • Open Access
8 Citations
5,633 Views
8 Pages

Towards On-Demand E. coli-Based Cell-Free Protein Synthesis of Tissue Plasminogen Activator

  • Seung-Ook Yang,
  • Gregory H. Nielsen,
  • Kristen M. Wilding,
  • Merideth A. Cooper,
  • David W. Wood and
  • Bradley C. Bundy

Stroke is the leading cause of death with over 5 million deaths worldwide each year. About 80% of strokes are ischemic strokes caused by blood clots. Tissue plasminogen activator (tPa) is the only FDA-approved drug to treat ischemic stroke with a who...

  • Article
  • Open Access
1 Citations
2,424 Views
9 Pages

Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models

  • Chung-Ze Wu,
  • Li-Chien Chang,
  • Chao-Wen Cheng,
  • Te-Chao Fang,
  • Yuh-Feng Lin,
  • Dee Pei and
  • Jin-Shuen Chen

In recent decades, the obesity epidemic has resulted in morbidity and mortality rates increasing globally. In this study, using obese mouse models, we investigated the relationship among urokinase plasminogen activator (uPA), metabolic disorders, glo...

  • Article
  • Open Access
15 Citations
3,385 Views
20 Pages

Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival

  • Elodie Hedou,
  • Sara Douceau,
  • Arnaud Chevilley,
  • Alexandre Varangot,
  • Audrey M. Thiebaut,
  • Hortense Triniac,
  • Isabelle Bardou,
  • Carine Ali,
  • Mike Maillasson and
  • Denis Vivien
  • + 5 authors

15 December 2021

Tissue-type plasminogen activator (tPA) plays roles in the development and the plasticity of the nervous system. Here, we demonstrate in neurons, that by opposition to the single chain form (sc-tPA), the two-chains form of tPA (tc-tPA) activates the...

  • Case Report
  • Open Access
5 Citations
572 Views
3 Pages

29 June 2016

Recombinant tissue plasminogen activator (rTPA) is one of the main portions of acute ischemic stroke management, but unfortunately has some complications. Myocardial infarction (MI) is a hazardous complication of administration of intravenous rTPA th...

  • Article
  • Open Access
11 Citations
3,628 Views
15 Pages

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies

  • Burcin Özdirik,
  • Anna Stueven,
  • Jana Knorr,
  • Lukas Geisler,
  • Raphael Mohr,
  • Münevver Demir,
  • Teresa Hellberg,
  • Sven H. Loosen,
  • Fabian Benz and
  • Christoph Roderburg
  • + 4 authors

Neuroendocrine neoplasia (NEN) comprises heterogeneous tumors that are challenging to diagnose and, especially in cases of poorly differentiated (G3) NEN, are associated with very limited survival. Novel biomarkers allowing an early diagnosis as well...

  • Article
  • Open Access
19 Citations
3,434 Views
14 Pages

12 March 2021

Autophagy plays a crucial role in maintenance of cellular homeostasis via intracellular signaling pathways, lysosomal degradation of selective cargo and mediating protein secretion. Dysregulation of autophagy has been implicated in tumorigenesis, tum...

  • Article
  • Open Access
38 Citations
9,188 Views
21 Pages

Synthesis and Characterization of Tissue Plasminogen Activator—Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution

  • Susanne Heid,
  • Harald Unterweger,
  • Rainer Tietze,
  • Ralf P. Friedrich,
  • Bianca Weigel,
  • Iwona Cicha,
  • Dietmar Eberbeck,
  • Aldo R. Boccaccini,
  • Christoph Alexiou and
  • Stefan Lyer

Superparamagnetic iron oxide nanoparticles (SPIONs) have attracted great attention in many biomedical fields and are used in preclinical/experimental drug delivery, hyperthermia and medical imaging. In this study, biocompatible magnetite drug carrier...

  • Article
  • Open Access
1 Citations
2,614 Views
13 Pages

4 December 2022

Cardiovascular disease is a major threat to global public health. Tissue plasminogen activator (TPA) is a serine protease that dissolves blood clots, which can also lead to excessive bleeding. Fibrinogen (FIBR), a glycoprotein, is converted by thromb...

  • Article
  • Open Access
5 Citations
2,849 Views
13 Pages

The Role of Plasminogen Activator Inhibitor 1 in Predicting Sepsis-Associated Liver Dysfunction: An Observational Study

  • Ewa Woźnica-Niesobska,
  • Patrycja Leśnik,
  • Jarosław Janc,
  • Małgorzata Zalewska and
  • Lidia Łysenko

Sepsis-associated liver dysfunction (SALD) is associated with a poor prognosis and increased mortality in the intensive care unit. Bilirubin is one of the components of Sequential Organ Failure Assessment used in Sepsis-3 criteria. Hyperbilirubinemia...

  • Article
  • Open Access
5 Citations
2,706 Views
17 Pages

Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis

  • Burcin Özdirik,
  • Martin Maibier,
  • Maria Scherf,
  • Jule Marie Nicklaus,
  • Josephine Frohme,
  • Tobias Puengel,
  • Dirk Meyer zum Büschenfelde,
  • Frank Tacke,
  • Tobias Mueller and
  • Michael Sigal

28 April 2022

The soluble urokinase-type plasminogen activator receptor (suPAR) has evolved as a useful biomarker for different entities of chronic liver disease. However, its role in patients with primary sclerosing cholangitis (PSC) is obscure. We analyzed plasm...

  • Article
  • Open Access
1,263 Views
11 Pages

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Erectile Dysfunction in Diabetic Patients

  • Osman Erinc,
  • Ozgur Yilmaz,
  • Tacettin Yekta Kaya,
  • Murvet Algemi and
  • Murat Akarsu

6 June 2025

Background/Objectives: Erectile dysfunction (ED) is a common complication of diabetes mellitus (DM), largely attributable to vascular, neurological and metabolic dysfunctions. Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of...

  • Article
  • Open Access
3 Citations
2,194 Views
10 Pages

3 March 2021

Soluble urokinase-type plasminogen activator receptor (suPAR) is a marker of immune activation and reflects a more distinct aspect of inflammation than C-reactive protein (CRP) does. The study concerns a clinically silent state of the immune system e...

  • Article
  • Open Access
14 Citations
3,705 Views
12 Pages

In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines

  • Enke Baldini,
  • Dario Presutti,
  • Pasqualino Favoriti,
  • Simonetta Santini,
  • Giuliana Papoff,
  • Chiara Tuccilli,
  • Raffaella Carletti,
  • Cira Di Gioia,
  • Eleonora Lori and
  • Salvatore Ulisse
  • + 8 authors

Increased expression of the urokinase-type plasminogen activator (uPA) system is associated with tumor invasion, neo-angiogenesis, and metastatic spread, and has been shown to positively correlate with a poor prognosis in several cancer types, includ...

  • Article
  • Open Access
9 Citations
2,678 Views
10 Pages

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Emergency Department (Ed): A Tool for the Assessment of Elderly Patients

  • Ria M. Holstein,
  • Santeri Seppälä,
  • Johanna Kaartinen,
  • Mari Hongisto,
  • Harri Hyppölä and
  • Maaret Castrén

8 June 2022

Emergency department (ED) overcrowding is a global issue setting challenges to all care providers. Elderly patients are frequent visitors of the ED and their risk stratification is demanding due to insufficient assessment methods. A prospective cohor...

  • Article
  • Open Access
2 Citations
1,944 Views
13 Pages

Effects of Combination Therapy with Intravitreal Ranibizumab and Tissue Plasminogen Activator for Neovascular Age-Related Macular Degeneration

  • Michiko Ando,
  • Aki Kato,
  • Masayo Kimura,
  • Shuntaro Ogura,
  • Soichiro Kuwayama,
  • Aoi Kominami,
  • Satoshi Kuwayama,
  • Tomohiro Obayashi,
  • Ryota Ando and
  • Tsutomu Yasukawa
  • + 2 authors

21 April 2024

Background: Subretinal hyper-reflective material (SHRM) sometimes causes vision loss in spite of anti-vascular endothelial growth factor (VEGF) therapy in eyes with neovascular age-related macular degeneration (nvAMD). We evaluated the impacts of com...

  • Brief Report
  • Open Access
2 Citations
2,333 Views
8 Pages

Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma

  • Ourania S. Kotsiou,
  • Ioannis Pantazopoulos,
  • Georgios Mavrovounis,
  • Konstantinos Marsitopoulos,
  • Konstantinos Tourlakopoulos,
  • Paraskevi Kirgou,
  • Zoe Daniil and
  • Konstantinos I. Gourgoulianis

28 October 2022

Introduction: The most clinically useful concept in asthma is based on the intensity of treatment required to achieve good asthma control. Biomarkers to guide therapy are needed. Aims: To investigate the role of circulating levels of soluble urokinas...

  • Article
  • Open Access
4 Citations
1,944 Views
10 Pages

4 March 2023

Cardiovascular diseases (CVDs) remain a significant cause of death in hemodialysis (HD) patients. To explore their associations, we examine the role of soluble urokinase-type plasminogen activator receptor (suPAR) in arterial stiffness in chronic HD...

  • Article
  • Open Access
6 Citations
3,968 Views
19 Pages

Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition

  • Kentaro Tokumo,
  • Takeshi Masuda,
  • Taku Nakashima,
  • Masashi Namba,
  • Kakuhiro Yamaguchi,
  • Shinjiro Sakamoto,
  • Yasushi Horimasu,
  • Shintaro Miyamoto,
  • Hiroshi Iwamoto and
  • Noboru Hattori
  • + 4 authors

8 February 2023

Most epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC) cells are killed within a few days after osimertinib treatment; however, surviving cells remain detectable and are called drug-tolerant cells. Plasminogen activat...

  • Article
  • Open Access
4 Citations
2,975 Views
10 Pages

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy

  • Soichiro Shibata,
  • Kenzo Sakurai,
  • Keiji Tachikawa,
  • Riyoko Ko,
  • Sakae Hino,
  • Takayuki Fukano,
  • Kenji Isahaya,
  • Takafumi Haraguchi,
  • Junji Yamauchi and
  • Yoshihisa Yamano
  • + 7 authors

21 November 2022

Purpose: This study aimed to investigate the accuracy and clinical significance of an artificial intelligence (AI)-based automated Alberta Stroke Program Early Computed Tomography (ASPECT) scoring software of head CT for the indication of intravenous...

  • Review
  • Open Access
24 Citations
7,425 Views
21 Pages

Plasminogen Activators in Neurovascular and Neurodegenerative Disorders

  • Manuel Yepes,
  • Yena Woo and
  • Cynthia Martin-Jimenez

The neurovascular unit (NVU) is a dynamic structure assembled by endothelial cells surrounded by a basement membrane, pericytes, astrocytes, microglia and neurons. A carefully coordinated interplay between these cellular and non-cellular components i...

  • Article
  • Open Access
4 Citations
3,417 Views
12 Pages

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Biomarker Associated with Left Ventricular Hypertrophy in the Elderly, Specifically in Women

  • Rafał Nikodem Wlazeł,
  • Agnieszka Guligowska,
  • Zuzanna Chrząstek,
  • Tomasz Kostka,
  • Anna Jegier and
  • Iwona Szadkowska

Left ventricular hypertrophy (LVH) may result in the development of heart failure, which is widespread among people of advanced age. The pathophysiology of LVH is complex and its biochemical pathways are not fully understood in this group. Elevated s...

  • Article
  • Open Access
5 Citations
2,850 Views
13 Pages

20 February 2022

Spheroids reproduce the tissue structure that is found in vivo more accurately than classic two-dimensional (2D) monolayer cultures. We cultured human periodontal ligament stem cells (HPLSCs) as spheroids that were embedded in collagen gel to examine...

  • Article
  • Open Access
11 Citations
4,549 Views
12 Pages

Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women

  • Jung Oh Kim,
  • Soo Hong Han,
  • Yeon Ho Lee,
  • Tae Keun Ahn,
  • Jae Joon Lim,
  • Young Sun Chung,
  • Dong Eun Shin,
  • Woo Sik Lee,
  • In Bo Han and
  • Nam Keun Kim

9 December 2016

Osteoporosis and osteoporotic fractures are strongly associated with mortality and morbidity, both in developing and developed countries. Menopause accelerates bone loss due to estrogen deficiency and age-related linear bone loss. We investigated pla...

  • Article
  • Open Access
9 Citations
2,798 Views
12 Pages

One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy

  • Yorihisa Kitagawa,
  • Hiroyuki Shimada,
  • Ryusaburo Mori,
  • Koji Tanaka,
  • Yu Wakatsuki,
  • Hajime Onoe,
  • Hiroyuki Kaneko,
  • Yumiko Machida and
  • Hiroyuki Nakashizuka

13 April 2022

This study investigated one-year outcomes of treatment with one session of intravitreal recombinant tissue plasminogen activator, ranibizumab, and gas injections for submacular hemorrhage secondary to polypoidal choroidal vasculopathy (PCV). An exten...

  • Article
  • Open Access
7 Citations
3,228 Views
19 Pages

20 November 2019

Background: The relationship between urokinase-type plasminogen activator (uPA) and the development of type 2 diabetes mellitus (T2DM) was investigated in the study by using mice and cell models, as well as patients with T2DM. Methods: In mice models...

  • Article
  • Open Access
16 Citations
3,191 Views
14 Pages

29 January 2023

Submacular hemorrhage (SMH) is the accumulation of blood in the macular area that can severely damage the macular structure and visual function. Recently, the intraocular administration of tissue plasminogen activator (TPA) with anti-vascular endothe...

of 16